Welcome to the Neuromodulation Society of Singapore

The Neuromodulation Society of Singapore (NSS) was formally established in 2025 in response to growing interest in advanced therapies within the region. We function as a national chapter aligned with the global International Neuromodulation Society network.

The NSS brings together clinicians, researchers, engineers, and allied professionals to promote the scientific, clinical, and public understanding of neuromodulation in Singapore and the region.

Learn More

Events

Image

Webinars 2026

Watch this space - coming soon starting January 2026!

Image

NSS Annual Meeting 2026

Watch this space - coming soon in March 2026!

Image

17th World Congress of the International Neuromodulation Society

Neuromodulation: Bridging Minds, Machines, and Medicine.
9-14 May 2026 | Lisbon, Portugal
https://ins-congress.com/ 

Abstract Submission is open until 15 October 2025.

Read More

News & Articles

Non-invasive brain stimulation (NIBS)

Non-invasive brain stimulation (NIBS) involve the application of energy forces such as electromagnetic or electrical stimulation to the scalp to alter the activity of neurons in targeted brain regions.

Read More

AI-Driven Models Help Personalize Deep Brain Stimulation to Improve Walking in Parkinson’s

August 5, 2025 - Researchers from University of California, San Francisco (UCSF) used mathematical models and AI to predict personalized deep brain stimulation (DBS) settings that improved gait in people with Parkinson’s disease. The study showcased that tailoring DBS based on individual brain activity could improve walking performance, pointing toward more effective, individualized therapies. (Source: Parkinson's News Today)

Read More

FDA Approves Vagus Nerve Stimulator for Rheumatoid Arthritis Treatment

July 31, 2025 - The FDA has approved a vagus nerve stimulation device developed by SetPoint Medical for treating moderate-to-severe rheumatoid arthritis in patients unresponsive to biologic or targeted synthetic DMARDs. Implanted in the neck and activated for one minute daily, the device showed clinical benefits in a year-long trial, with plans for U.S. commercialization beginning in select US cities in late 2025. (Source: Medscape)

Read More